Gil Price, MD

Chief Medical Officer

Dr. Gil Price is a clinical physician trained in Internal medicine. He has a long-standing interest in novel drug development, drug utilization, pharmaceutical and biotechnology government regulation. He is an accomplished senior level manager with over 30 years of diverse therapeutic experience. His responsibilities have included clinical program development, global pharmacovigilance, and regulatory oversite.

Dr. Price currently serves as the Chief Medical Officer for ProPharma Group’s Pharmacovigilance team. Before joining ProPharma Group, Dr. Price served as CEO of Drug Safety Solutions, recently acquired by ProPharma Group. Dr. Price has also served as the Director of Clinical Development for oncology at MedImmune, Inc., the biologics subsidiary of AstraZeneca. Dr Price began his pharmaceutical career at Glaxo Inc. in Research Triangle Park, NC. While there, he worked nearly nine years in roles of increasing responsibility on both the commercial and research sides of the company.

Dr. Price is a former member of the American Medical Association, The Academy of Pharmaceutical Physicians and the American Society of Microbiology.

Company Blog

April 3, 2018
Understanding the New Combination Product PMSR Guidance Documents and Impact…
Take a closer look at new FDA guidance documents surrounding postmarketing safety reporting (PMSR)… Read More
March 28, 2018
What to Expect From a FDA Inspection, Part 2
Are you prepared for a FDA inspection? In the final installment of this two-part… Read More
March 26, 2018
MassBio Annual Meeting: Event Highlights
Key highlights from the 2018 MassBio Annual Meeting. Read More
More Articles


April 24, 2018
CPhI North America
Meet the ProPharma Group team at CPhI North America! CPhI North America will show you the connective power of ... Read More
April 25, 2018
ISPE Midwest Tech Ed Day
ProPharma Group Senior Manager, Simona Mills, PMP will be speaking at the event, on Compliance in an Aging Fac... Read More
June 04, 2018
BIO International
The BIO International Convention  attracts more than 16,000 biotechnology and pharma leaders who come togethe... Read More
All Events
Contact Us